Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R D'Adamo

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Seminars in Oncology|November 8, 2011
Appraising the current role of chemotherapy for the treatment of sarcomaDavid R D'Adamo
Mayo Clinic Proceedings|November 3, 2007
SarcomaKeith M Skubitz, David R D'Adamo
BMJ Case Reports|April 13, 2018
Treatment-refractory ALK-positive inflammatory myofibroblastic tumour of the oral cavityAnna W LaVigne, David M Meredith, David R D'Adamo, et al.
Sarcoma|May 15, 2007
A retrospective analysis of vinorelbine chemotherapy for patients with previously treated soft-tissue sarcomasSibyl E Anderson, Mary L Keohan, David R D'Adamo, et al.
British Journal of Cancer|May 9, 2019
Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised studyJean-Yves Blay, Patrick Schöffski, Sebastian Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomasDavid R D'Adamo, Sibyl E Anderson, Karen Albritton, et al.
Cancer|February 27, 2010
Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor)Veridiana Pires de Camargo, Mary L Keohan, David R D'Adamo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Activity of Sorafenib against desmoid tumor/deep fibromatosisMrinal M Gounder, Robert A Lefkowitz, Mary Louise Keohan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2012
The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trialJason J Luke, David R D'Adamo, Mark A Dickson, et al.
Cancer|October 28, 2008
Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapyAlex D Drilon, Sanjay Popat, Gauri Bhuchar, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Seminars in Oncology|November 8, 2011
Appraising the current role of chemotherapy for the treatment of sarcomaDavid R D'Adamo
Mayo Clinic Proceedings|November 3, 2007
SarcomaKeith M Skubitz, David R D'Adamo
BMJ Case Reports|April 13, 2018
Treatment-refractory ALK-positive inflammatory myofibroblastic tumour of the oral cavityAnna W LaVigne, David M Meredith, David R D'Adamo, et al.
Sarcoma|May 15, 2007
A retrospective analysis of vinorelbine chemotherapy for patients with previously treated soft-tissue sarcomasSibyl E Anderson, Mary L Keohan, David R D'Adamo, et al.
British Journal of Cancer|May 9, 2019
Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised studyJean-Yves Blay, Patrick Schöffski, Sebastian Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomasDavid R D'Adamo, Sibyl E Anderson, Karen Albritton, et al.
Cancer|February 27, 2010
Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor)Veridiana Pires de Camargo, Mary L Keohan, David R D'Adamo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2011
Activity of Sorafenib against desmoid tumor/deep fibromatosisMrinal M Gounder, Robert A Lefkowitz, Mary Louise Keohan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2012
The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trialJason J Luke, David R D'Adamo, Mark A Dickson, et al.
Cancer|October 28, 2008
Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapyAlex D Drilon, Sanjay Popat, Gauri Bhuchar, et al.
Pageof 3